• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期评估肝微波消融后凝固性坏死:非增强与增强 T1 加权图像比较。

Early assessment of coagulation necrosis after hepatic microwave ablation: a comparison of non-enhanced and enhanced T1-weighted images.

机构信息

Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Gulou district, Nanjing, 210029, Jiangsu, China.

出版信息

Abdom Radiol (NY). 2017 Jun;42(6):1781-1787. doi: 10.1007/s00261-017-1064-0.

DOI:10.1007/s00261-017-1064-0
PMID:28180923
Abstract

PURPOSE

To compare the technical success and accuracy of hepatic microwave ablation (MWA) using non-enhanced and enhanced T1-weighted imaging early after ablation. Patients were evaluated with regard to the ablation zone and local tumor progression (LTP).

METHODS

This retrospective study conducted between September 2014 and December 2015 which consisted of 56 patients with 56 hepatic malignant lesions who underwent percutaneous MWA. Non-enhanced and contrast-enhanced T1-weighted imagings were performed within 2 days after tumor ablation. The efficacy of ablation assessed according to the hyperintense middle zone on non-enhanced T1-weighted images and the non-enhanced area on contrast-enhanced T1-weighted images were compared. The development of LTP during ≥7 months of follow-up served as the end point.

RESULTS

On the non-enhanced T1-weighted images, the ablated region had a characteristic two-zone structure featuring a hyperintense middle zone and a surrounding hypointense band. Among the 56 patients, LTP developed in ten including seven lesions, in which both the non-enhanced T1-weighted and portal-phase images showed incomplete tumor ablation. In two of the remaining three patients, incomplete tumor ablation was detected on the non-enhanced T1-weighted images, whereas the corresponding portal-phase images showed complete ablation. In the remaining patient, no residual tumor was detected on either the non-enhanced T1-weighted or the portal-phase images. In the 46 patients without LTP, there was no evidence of residual tumor on the non-enhanced T1-weighted or portal-phase images obtained early after ablation.

CONCLUSIONS

Non-enhanced T1-weighted images are useful in assessing the therapeutic efficacy of MWA of liver tumors early after the procedure.

摘要

目的

比较肝微波消融(MWA)术后即刻非增强和增强 T1 加权成像在技术成功率和准确性方面的差异,评估消融区域和局部肿瘤进展(LTP)。

方法

本回顾性研究于 2014 年 9 月至 2015 年 12 月期间进行,共纳入 56 例 56 个肝恶性肿瘤患者,均接受经皮 MWA 治疗。肿瘤消融术后 2 天内行非增强和增强 T1 加权成像检查。根据非增强 T1 加权图像上的高信号中间区和增强 T1 加权图像上的无增强区评估消融效果,并进行比较。以≥7 个月随访期间 LTP 的发展为终点。

结果

在非增强 T1 加权图像上,消融区域呈现出特征性的两区域结构,表现为高信号中间区和周围低信号带。在 56 例患者中,10 例(7 个病灶)发生 LTP,其中非增强 T1 加权图像和门静脉期图像均显示肿瘤不完全消融。在其余 3 例患者中的 2 例中,仅在非增强 T1 加权图像上检测到肿瘤不完全消融,而相应的门静脉期图像显示完全消融。在其余 1 例患者中,非增强 T1 加权图像和门静脉期图像上均未检测到残留肿瘤。在无 LTP 的 46 例患者中,术后即刻非增强 T1 加权图像和门静脉期图像均未见残留肿瘤。

结论

非增强 T1 加权图像有助于评估肝肿瘤 MWA 术后即刻的疗效。

相似文献

1
Early assessment of coagulation necrosis after hepatic microwave ablation: a comparison of non-enhanced and enhanced T1-weighted images.早期评估肝微波消融后凝固性坏死:非增强与增强 T1 加权图像比较。
Abdom Radiol (NY). 2017 Jun;42(6):1781-1787. doi: 10.1007/s00261-017-1064-0.
2
Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.肝细胞癌不可逆电穿孔:磁共振成像、计算机断层扫描及超声造影在评估消融区域诊断准确性的初步报告
Radiol Med. 2016 Feb;121(2):122-31. doi: 10.1007/s11547-015-0582-5. Epub 2015 Sep 7.
3
Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones.1.5T 磁共振引导下射频消融治疗的 T1 及 T2 加权序列的治疗监测:消融区的可靠性评估。
Invest Radiol. 2013 Jun;48(6):429-36. doi: 10.1097/RLI.0b013e318280b007.
4
Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response.热消融治疗恶性肝病变:10 年治疗反应的 MRI 表现经验。
AJR Am J Roentgenol. 2010 Feb;194(2):523-9. doi: 10.2214/AJR.09.2621.
5
Efficacy, safety and feasibility of ultrasound-guided percutaneous microwave ablation for large hepatic hemangioma.超声引导下经皮微波消融治疗巨大肝血管瘤的疗效、安全性及可行性
J Dig Dis. 2015 Sep;16(9):525-30. doi: 10.1111/1751-2980.12169.
6
Microwave ablation of liver tumors: degree of tissue contraction as compared to RF ablation.微波消融治疗肝脏肿瘤:与射频消融相比组织收缩程度。
Abdom Radiol (NY). 2016 Apr;41(4):659-66. doi: 10.1007/s00261-016-0725-8.
7
Diagnostic accuracy of different magnetic resonance imaging sequences for detecting local tumor progression after radiofrequency ablation of hepatic malignancies.不同磁共振成像序列检测肝恶性肿瘤射频消融后局部肿瘤进展的诊断准确性。
Eur J Radiol. 2017 Sep;94:85-92. doi: 10.1016/j.ejrad.2017.06.009. Epub 2017 Jun 17.
8
Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases.微波消融治疗经动脉化疗栓塞后合并布加综合征的肝细胞癌:十例分析。
Abdom Radiol (NY). 2017 Mar;42(3):962-968. doi: 10.1007/s00261-016-0923-4.
9
Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.肝硬化中的肝细胞癌:钆和超顺磁性氧化铁增强T1加权磁共振成像的强化模式
Radiology. 2005 Nov;237(2):520-8. doi: 10.1148/radiol.2372041183. Epub 2005 Sep 28.
10
Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.肝细胞癌经皮射频消融治疗反应评估:对比剂增强检测成像的应用价值
Eur J Radiol. 2005 Oct;56(1):66-73. doi: 10.1016/j.ejrad.2005.03.023.

引用本文的文献

1
Evaluating Pre-Interventional Administration of a Liver-Specific Contrast Agent During MRI-Guided Thermal Ablation of Malignant Liver Lesions.在磁共振成像(MRI)引导下对恶性肝脏病变进行热消融期间评估肝脏特异性造影剂的介入前给药情况。
Cancers (Basel). 2025 Apr 9;17(8):1264. doi: 10.3390/cancers17081264.
2
A Review of Imaging Methods to Assess Ultrasound-Mediated Ablation.评估超声介导消融的成像方法综述
BME Front. 2022;2022. doi: 10.34133/2022/9758652. Epub 2022 May 2.
3
Microwave Ablation of Small Hepatic Metastases Using MR Guidance and Monitoring: Clinical Safety and Efficacy.
使用磁共振引导和监测对小肝转移瘤进行微波消融:临床安全性和有效性
Cancer Manag Res. 2021 Apr 16;13:3357-3366. doi: 10.2147/CMAR.S301856. eCollection 2021.